REPROCELL Achieves Major GMP Certification for Stem Cell Manufacturing

REPROCELL Achieves Major GMP Certification for Stem Cell Manufacturing

REPROCELL, based at NETPark, has reached a major milestone in regenerative medicine.

NETPark-based biotech innovator REPROCELL, in partnership with Histocell, has achieved a major milestone: GMP certification from Spain’s AEMPS for the manufacturing of clinical-grade iPSC Master and Working Cell Banks using REPROCELL’s proprietary StemRNA™ technology.

The certification ensures compliance with European Medicines Agency (EMA) standards and supports global regulatory alignment, including with the FDA and PMDA. It enables the scalable, safe, and compliant production of stem cell therapies for clinical use worldwide.

This achievement strengthens NETPark’s reputation as a centre for cutting-edge life sciences and regenerative medicine.